Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | L330H |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 L330H lies within the tetramerization domain of the Tp53 protein (PMID: 20978130). L330H results in decreased Tp53 tetramerization and transcriptional activity in cell culture (PMID: 19454241, PMID: 9766574). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon9 TP53 L330H TP53 mutant TP53 inact mut TP53 L330H |
Transcript | NM_000546.6 |
gDNA | chr17:g.7673539A>T |
cDNA | c.989T>A |
Protein | p.L330H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126113.3 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001276760 | chr17:g.7669684_7669685delCAinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126118 | chr17:g.7669684_7669685delCAinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407267.1 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001276760.3 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126118.2 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001276761.1 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001276760.1 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001276761.3 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126118.1 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407263.1 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407265.1 | chr17:g.7669684_7669685delTGinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
NM_001276761 | chr17:g.7669684_7669685delCAinsAT | c.989_990delTGinsAT | p.L330H | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7673539A>T | c.989T>A | p.L330H | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|